Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
pyridoxine
doxylamine |
| gptkbp:alsoKnownAs |
Debendox
Diclectin |
| gptkbp:category |
antihistamine
antiemetic vitamin B6 preparation |
| gptkbp:contains |
gptkb:doxylamine_succinate
pyridoxine hydrochloride |
| gptkbp:form |
oral tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bendectin
|
| gptkbp:introducedIn |
1956
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merrell_Dow_Pharmaceuticals
|
| gptkbp:regulates |
approved (historically)
|
| gptkbp:retired |
litigation over alleged birth defects
|
| gptkbp:scientificConsensus |
not proven to cause birth defects
|
| gptkbp:status |
not available in US
available as Debendox in UK available as Diclectin in Canada |
| gptkbp:studiedBy |
teratogenicity
|
| gptkbp:usedFor |
nausea and vomiting of pregnancy
|
| gptkbp:withdrawn |
1983
|
| gptkbp:withdrawnFrom |
gptkb:United_States
|
| gptkbp:bfsParent |
gptkb:Merrell_Dow_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|